Getaneh, Abraham M.Heijnsdijk, Eveline A.M.Roobol, Monique J.de Koning, Harry J.2023-04-262023-04-262020-10-01Getaneh, A M, Heijnsdijk, E A M, Roobol, M J & de Koning, H J 2020, 'Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening : A micro-simulation study of 230 scenarios', Cancer Medicine, vol. 9, no. 20, pp. 7742-7750. https://doi.org/10.1002/cam4.33952045-7634https://hdl.handle.net/2164/20571Funding Information: This publication was made possible by Grant number 1U01CA199338 from National Cancer Institute as part of Cancer Intervention and Surveillance Modeling Network (CISNET). Its contents are solely the responsiblity of the authors and do not necessarily represent the official views of the National Cancer Institute. Publisher Copyright: © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.9299278engSDG 3 - Good Health and Well-beingharms and benefits; cost-effectivenessmicro-simulationprostate cancerprostate-specific antigen (PSA) screeningRC0254 Neoplasms. Tumors. Oncology (including Cancer)OncologyRadiology Nuclear Medicine and imagingCancer ResearchRC0254Journal article10.1002/cam4.3395http://www.scopus.com/inward/record.url?scp=85089522557&partnerID=8YFLogxK920